Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.
Satoh-Asahara N, Suganami T, Majima T, Kotani K, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Himeno A, Kono S, Sugawara A, Hattori M, Ogawa Y, Shimatsu A; Japan Obesity and Metabolic Syndrome Study (JOMS) Group.
Satoh-Asahara N, et al. Among authors: kono s.
Clin J Am Soc Nephrol. 2011 Feb;6(2):265-73. doi: 10.2215/CJN.04830610. Epub 2010 Nov 4.
Clin J Am Soc Nephrol. 2011.
PMID: 21051748
Free PMC article.